Unlike frequently mutated UTX in cancers such as breast, renal cell carcinoma, and acute myeloid leukaemia, UTY's contributions in cancer are less defined, constrained by male-specific expression. The gene discussed is KDM6A; the disease is hereditary clear cell renal cell carcinoma.